The objective was to demonstrate the build and use of a low-cost, moderate-fidelity simulation model for LeFort colpocleisis. We a present a video demonstrating the creation of a LeFort colpocleisis model, the mounting of this model to a pre-existing vaginal hysterectomy simulator (SimVaHT), and the use of the model to teach the steps of the LeFort colpocleisis procedure. This LeFort colpocleisis model is easy to make, from readily available materials, and is inexpensive. It can help trainees to enhance their intraoperative learning.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s00192-021-04902-y | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
LeFort Colpocleisis: Unmet Expectations about Correction of Urinary Symptoms Are Related to Disappointment and Regret.
J Midlife Health
October 2024
1 Department of Obstetrics and Gynecoloogy, Papageorgiou General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Article Synopsis
- The study aimed to evaluate the long-term outcomes, satisfaction, and reasons for disappointment in patients with advanced pelvic organ prolapse who underwent LeFort colpocleisis (LFC).
- Conducted between 2007 and 2021, the study included 141 patients and used surveys to assess their health and satisfaction 61.65 months after surgery.
- Results indicated a low rate of prolapse recurrence and no regrets about sexual function loss; however, persistent urinary incontinence correlated with decreased satisfaction and regret.
The "Repeat Colpocleisis": A Literature Review and Case Report.
Int Urogynecol J
August 2024
Division of Urogynecology and Reconstructive Pelvic Surgery, Harbor-UCLA Medical Center, 1000 W Carson Avenue, Los Angeles, CA, 90502, USA.
Introduction And Hypothesis: Colpocleisis is a surgical procedure intended to treat pelvic organ prolapse. Compared with other modes of pelvic reconstructive surgery, colpocleisis is associated with lower morbidity and higher satisfaction, and has a success rate of 91-100% and a reoperation rate of less than 2%. However, there is limited information on how to treat recurrent prolapse after colpocleisis.
View Article and Find Full Text PDFPredicting the occurrence of stress urinary incontinence after prolapse surgery: a machine learning-based model.
Ann Transl Med
March 2023
National Clinical Research Center for Obstetric & Gynecologic Diseases, Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
Background: Previous prediction models for postoperative stress urinary incontinence (SUI) cannot be applied to patients receiving transvaginal mesh (TVM) surgery and colpocleisis or those with preoperative subject urinary incontinence. This study aimed to develop and validate a new machine learning model and compare it to previous models.
Methods: Female patients who underwent prolapse surgeries for stage 2-4 anterior or apical prolapse between January 1, 2015, and December 31, 2019, at Peking Union Medical College Hospital were enrolled.
Colpocleisis Techniques: An Open-and-shut Case for Advanced Pelvic Organ Prolapse.
Urology
June 2023
Division of Urogynecology, Walter Reed National Military Medical Center, Bethesda, MD.
Objective: To highlight several advanced surgical techniques for all types of colpocleisis. Pelvic organ prolapse is a common condition that affects up to 40% of the postmenopausal female population. Particularly for women with advanced pelvic organ prolapse who no longer desire penetrative vaginal intercourse and with multiple medical comorbidities, the obliterative approach is preferred due to decreased anesthetic needs, operative time, and perioperative morbidity.
View Article and Find Full Text PDF[How I do… A colpocleisis without hysterectomy (Lefort procedure) for a cure of vaginal prolapse ?].
Gynecol Obstet Fertil Senol
April 2023
Assistance Publique des hôpitaux de Paris (AP-HP), Department of Gynecological and Breast Surgery and Oncology, Pitié-Salpêtrière University Hospital, 75013 Paris, France; Cancer Biology and Therapeutics, centre de recherche Saint-Antoine (CRSA), Sorbonne University, Inserm UMR_S_938, 75012 Paris, France. Electronic address:
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!